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Renal cell carcinoma (RCC) accounts for 80–85% of all primary renal neoplasms. Although RCC can metastasize to any organ,
gastric metastases from RCC are exceedingly rare. A 67-year-old male presented with melena and acute blood loss anemia. The
patient had a history of RCC that had been treated with a radical nephrectomy. He had a recent myocardial infarction and was
receiving double antiplatelet therapy. After hemodynamic stabilization, esophagogastroduodenoscopy showed a polypoid mass in
the gastric fundus. The mass was excised. Histological and immunohistochemical evaluation were consistent with clear cell RCC.
The polypoid lesion is consistent with a late solitary metastasis.
1. Introduction
Renal cell carcinoma (RCC) is themost common cancer orig-
inating from the kidney [1]. Lungs, bones, liver, and brain are
the most common sites of RCCmetastasis [2, 3]. Uncommon
metastatic sites, including the gastrointestinal tract [2–4],
have also been reported. Gastric metastasis from RCC is rare
[5, 6]. Gastric metastases are typically asymptomatic, single,
and located in the gastric body or fundus [5, 6]. If they are
symptomatic, then gastrointestinal bleeding and anemia are
themost common presentations [5, 6]. RCC has the potential
for late solitary metastasis. Isolated gastric metastasis from
RCC can occur up to 20 years after radical nephrectomy [7].
Immunohistochemistry is useful and increasingly utilized in
the diagnosis of RCC [8, 9]. The prognosis in patients with
metastatic RCC is generally poor, with a five-year survival
rate of 5–30% [10]. Treatment options include embolization
and epinephrine injection for bleeding and endoscopic resec-
tion or surgery [11–16]. Surgical resection remains the best
therapeutic option for a solitary gastric metastasis, resulting
in significant survival prolongation in eligible patients [8].
2. Case Summary
A 67-year-old man presented with multiple episodes of
melena. His past medical history involved polycystic kidney
disease, live donor renal transplantation in 2002 with chronic
immunosuppression, and metastatic left-sided RCC that had
been treated with radical nephrectomy and the resection of
a pulmonary metastasis in 2014. The patient had chronic
kidney disease, stage 3, and a recent ST segment elevation
myocardial infarction with percutaneous coronary interven-
tion and drug eluting stent insertion. The patient was on
81mg of aspirin daily and 90mg of ticagrelor twice daily.
His vital signs on presentation were blood pressure of
121/82mmHg, pulse of 105 bpm, and oral temperature of
97.7∘F (36.5 C). On physical examination, the patient was pale
and inmild distress. Abdominal and cardiopulmonary exams
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Figure 1: EGD showing a 2.5 to 3.0 cm polypoid mass in the gastric
fundus.
were unremarkable. Initial laboratory evaluation included
a hemoglobin (Hb) level of 8.8 g/dl (normal: 13.5–17.5 g/dl),
white blood cell (WBC) count of 11,300/cmm (normal:
4,000–11,000/cmm), platelet count of 344,000 cmm (normal:
150,000–450,000/cmm), serum creatinine level of 2.3mg/dl
(normal: 0.9–1.2mg/dl), aspartate aminotransferase level of
27 units/L (normal: 15–46 units/L), alanine aminotransferase
level of 14 units/L (normal: 13–69 units/L), alkaline phos-
phatase level of 117 units/L (normal: 42–140 units/L), and
international normalized ratio of 1.2. The patient was admit-
ted for stabilization and further evaluation of gastrointestinal
bleeding.
The patient was intravenously given 80mg pantoprazole,
followed by 8mg/hour continuous infusion. A total of 2 units
of packed red blood cells were transfused. Aspirin and tica-
grelor were initially held. On hospitalization day 1, the patient
was hemodynamically stable and his Hb level increased to
9.9 g/dl after transfusion. The gastroenterology service pro-
ceeded with esophagogastroduodenoscopy (EGD).The EGD
(Figure 1) showed a 2.5 to 3.0 cm polypoid mass in the gastric
fundus. The polyp was completely removed with a polypec-
tomy snare and cautery. Bleeding occurred after polyp
removal, and hemostasis was achieved via local epinephrine
injection and the application of two Cook hemostasis clips.
The histological examination (Figure 2) demonstrated a
submucosal tumor comprising nests and fascicles of cells
with abundant clear cytoplasm and moderately pleomorphic
nuclei with prominent eosinophilic nucleoli. A background
vascular network and acute and chronic inflammation were
observed. Immunohistochemical staining (Figure 3) was
positive for pan-keratin PAX2 and PAX8. Both the mor-
phology and immune phenotypes were most consistent with
metastatic clear cell RCC, comparable with the right lung
lesion resected in 2014.
The patient was observed overnight in the intensive
care unit. His Hb levels were unchanged, and he remained
hemodynamically stable. Aspirin and ticagrelor treatments
were resumed.The oncology service decided to follow him as
an outpatient. Chemotherapywas not initiatedwith his recent
gastrointestinal blood loss and myocardial infarction. He is
following up now with the oncology and cardiology clinics
and has been doing well about 1 year after his presentation.
Figure 2: Histological evaluation including H&E staining, showing
a tumor comprising nests and fascicles of cells with abundant
clear cytoplasm andmoderately pleomorphic nuclei with prominent
eosinophilic nucleoli.
Figure 3: Positive immunohistochemical staining for PAX-2, con-
sistent with clear cell RCC.
3. Discussion
RCC is themost common cancer originating from the kidney.
This cancer is responsible for 80 to 85% of all primary renal
neoplasms and accounts for 3% of all adult malignancies [1].
RCC has an abundant blood supply and can metastasize to
any organ [2, 3].Themost common sites ofmetastasis include
the lungs, bones, liver, and brain [2, 3]. However, RCCs can
also metastasize to unusual sites, including the pancreas,
thyroid gland, adrenal gland, skeletal muscle, and skin [4].
Studies have reported that a metastasis is detected in approx-
imately 30% of RCC patients on initial presentation [3].
Gastric metastases from RCC are exceedingly rare [5, 6].
Pollheimer et al. [5] reported 5 patientswhodeveloped gastric
metastases from an Austrian database of 2,082 RCC patients.
In one instance, an isolated gastric metastasis from RCC
was reported 20 years after radical nephrectomy [7]. Table 1
summarizes the reported cases of gastric metastases from
RCC in English literature.
Most RCC gastric metastases are located in the gastric
body and fundus. Single tumors predominate over multiple
tumors [6]. Histologically, thesemetastases are situated in the
submucosa [3, 12]. Clear cell histology is the predominant
form of RCC. The presence of clear cell morphology in any
unknown lesion should prompt the pathologist to consider
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Table 1: Reported cases of gastric metastases from RCC in English literature.
Case and reference Age (years), sex Gastrointestinalsymptoms Location Gross appearance Histology Treatment
Sullivan et al. 1980 [17] 69, male Bleeding Antrum Mass, single Not specified Antrectomy
Boruchowicz et al. 1995 [18] 48, male Dysphagia Fundus Polypoid, single Clear cell Chemotherapy
Blake et al. 1995 [11] 63, male Bleeding Not specified Not specified Not specified Embolization
Odori et al. 1998 [19] 58, male Not specified Not specified Ulcerated, single Clear cell
Total gastrectomy
with regional
lymph node
dissection
Picchio et al. 2000 [12] 64, female Bleeding Body Polyp, single Clear cell Subtotalgastrectomy
Mascarenhas et al. 2001 [20] 66, male Bleeding Body Ulcerated, single Clear cell Partialgastrectomy
Kobayashi et al. 2004 [21] 78, male Anemia Lower one-thirdof stomach Mass, single Not specified Gastrectomy
Kok Wee et al. 2004 [7] 60, male Bleeding Body
2 lesions,
protruding and
ulcerated
Clear cell Endoscopictherapy
Lamb et al. 2005 [13] 69, male Bleeding Body Mass, single Clear cell Embolization,octreotide
Riviello et al. 2006 [22] 68, male Bleeding Fundus Mass, single Clear cell
Total
gastrectomy,
chemotherapy
Pezzoli et al. 2007 [15] 78, male Anemia Body Polyps, multiple Clear cell Endoscopicmucosal resection
Saidi and Remine 2007 [23] Not specified Bleeding Body Polyp, single Clear cell Wedge resection
Pollheimer et al. 2008 [5] 69, male Epigastric pain,Nausea, vomiting Body Mass, single Clear cell Tamoxifen
Pollheimer et al. 2008 [5] 77, male No symptoms Antrum Ulcerated, single Clear cell Interferon
Pollheimer et al. 2008 [5] 83, female Bleeding Antrum Mass, multiple Clear cell
Endoscopic
therapy,
interferon
Pollheimer et al. 2008 [5] 65, female Bleeding Not specified Multiple Clear cell Endoscopictherapy
Pollheimer et al. 2008 [5] 69, male Anemia,epigastric pain Body Multiple Clear cell
Endoscopic
therapy, sunitinib
Kibria et al. 2009 [24] 53, male Bleeding Fundus Polypoid, single Clear cell None
Yamamoto et al. 2009 [8] 74, male Bleeding Body Polypoid, single Not specified Wedge resection
Tiwari et al. 2010 [25] 58, female Bleeding Antrum Polypoid, single Clear cell Subtotalgastrectomy
Garc´ıa-Campelo et al. 2010 [26] 75, male No symptoms Fundus andbody Polypoid, multiple Not specified Sunitinib
Sugasawa et al. 2010 [27] 69, male Anemia Fundus Ulcerated, single Clear cell Wedge resection
Eslick and Kalantar 2011 [28] 65, male Bleeding Lower stomach Polypoid, single Clear cell Polypectomy
Kim et al. 2012 [29] 79, male Abdominal pain Body Erosive, single Clear cell Partialgastrectomy
Xu et al. 2012 [30] 60, male Anemia Body Polyp, multiple Clear cell
Polypectomy,
sunitinib,
sorafenib
Siriwardana et al. 2012 [31] 71, male Anemia Not specified Polypoid, single Clear cell Endoscopicmucosal resection
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Table 1: Continued.
Case and reference Age (years), sex Gastrointestinalsymptoms Location Gross appearance Histology Treatment
Namikawa et al. 2012 [32] 65, male Not specified Body Polypoid, single Clear cell Wedge resection
Rodrigues et al. 2012 [33] 45, female Bleeding Body Ulcerated, single Not specified Sunitinib
Chibbar et al. 2013 [34] 69, female Anemia Body Polypoid, single Clear cell Endoscopicmucosal resection
Rita et al. 2014 [6] 77, male Bleeding,abdominal pain Body Polypoid, single Clear cell
Endoscopic
resection
Greenwald et al. 2014 [35] 62, male No symptoms Fundus Mass, single Clear cell Partialgastrectomy
Costa et al. 2014 [36] 66, female Anemia Body Ulcerated, single Not specified Laparoscopicwedge resection
Kumcu et al. 2014 [37] 59, male Bleeding, weightloss Body Polypoid, single Clear cell
Partial
gastrectomy
Sakurai et al. 2014 [38] 62, male Bleeding, anemia Body Mass, single Clear cell Partialgastrectomy
Forman et al. 2015 [39] 76, female Bleeding, anemia Cardia Mass, single Clear cell Not specified
Kongnyuy et al. 2016 [40] 68, male Anemia,bleeding Fundus Mass, single Clear cell Not specified
Our case 2016 67, male Bleeding Fundus Polypoid, single Clear cell
Polypectomy,
plan for
chemotherapy
the possibility of metastatic RCC, even in the absence of a
prior diagnosis [30]. Endoscopically, the metastasis typically
appears as a polypoid submucosal-like tumor with a central
depression.
In general, the outcome withmetastatic RCC is poor with
5-year survival rates of 5–30% [10]. Patients with a single
metastasis fare better than those with multiple metastases.
Immunohistochemistry, particularly for vimentin and
PAX-2, is a useful adjunct in the diagnosis of RCC [8,
9]. Vimentin is an intermediate filament protein expressed
in normal renal tissues [8], and PAX-2 is a transcription
factor required for the development and proliferation of renal
tubules [9]. Both proteins are expressed in 85% of metastatic
clear cell RCCs [8, 9].
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